U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Pharmacy Compounding Advisory Committee
  6. Pharmacy Compounding Advisory Committee Roster
  1. Pharmacy Compounding Advisory Committee

Pharmacy Compounding Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info

Current Number of Vacancies = 2
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Padma Gulur, MD FASA
Expertise: Anesthesiology
Term: 12/18/2020 – 9/30/2024
Professor of Anesthesiology and Population Health
Executive Vice Chair
Department of Anesthesiology
Director of Pain Management Strategy and Opioid Surveillance
Duke University Health System
Duke University Medical Center
Durham, North Carolina 27710

Designated Federal Officer (DFO)
Takyiah Stevenson, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: PCAC@fda.hhs.gov

Robin H. Bogner, PhD
Expertise: Pharmaceutical Formulation and Processing, Pharmacy Compounding
Term: 12/18/2020 – 9/30/2024
Professor
University of Connecticut
School of Pharmacy
Department of Pharmaceutical Sciences
69 North Eagleville Road, PBB 438
Storrs, Connecticut 06269

Seemal R. Desai, MD, FAAD
Expertise: Dermatology
Term: 10/1/2017-9/30/2025
Founder and Medical Director
Innovative Dermatology
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
5425 West Spring Creek Parkway, Suite 265
Plano, Texas 75024

Timothy D. Fensky, RPh, DPh FACA
Expertise: National Association of Boards of Pharmacy Representative
Term: 10/1/2018 – 9/30/2026
Chief Pharmacy Operations Officer
Sullivan’s Pharmacy and Medical Supply, Inc.
Sullivan's Health Care, Inc.
30 Belgrade Avenue
Roslindale, Massachusetts 02131

Anita Gupta, DO, MPP, GMP, PharmD, FASA
Expertise: Anesthesiology, Pain, Health Policy, Pharmacology, General Management
Term: 12/18/2020 – 9/30/2024
Assistant Professor, Adjunct
Johns Hopkins School of Medicine
Department of Anesthesiology and Critical Care
600 North Wolfe Street
Baltimore, Maryland 21205
Chief Executive Officer

Kathleen M. Gura PharmD, BCNSP, FASHP, FASPEN
Expertise: Pediatrics, Gastrointestinal Medicine
Term: 12/18/2020 – 9/30/2024
Assistant Professor of Pediatrics
Harvard Medical School
Manager, Pharmacy Clinical Research Program
Boston Children’s Hospital
300 Longwood Avenue
Department of Pharmacy, Main Subbasement
Boston, Massachusetts 02115

**Thomas J. Lupton, PharmD, MBA, BCPS
Expertise: Pharmacy Compounding
Term: 2/8/2024 to 10/31/2027
Director, Point-of-Care Pharmacy Services
On Demand Pharmaceuticals
1550 East Gude Drive
Rockville, Maryland 20850

Linda F. McElhiney, PharmD, RPh, MSP, FAPC, FACA, FASHP, DPLA
Expertise: Pharmacy Compounding
Term: 11/14/2019 – 9/30/2027
Team Lead Compounding Pharmacist
Indiana University Health
750 Riley Hospital Drive, SFT W6111
Indianapolis, Indiana 46202

Elizabeth Rebello, RPh, MD, FASA, CPPS, CMQ
Expertise: Anesthesiology
Term: 10/1/2018– 9/30/2026
Professor
Department of Anesthesiology and Perioperative Medicine
University of Texas MD Anderson Cancer Center
1400 Holcombe Boulevard
Houston, Texas 77030

Brian Serumaga, PhD
Expertise: United States Pharmacopeia Representative
Term: 4/23/2022 – 9/30/2026
Senior Manager, Personalized Medicines
United States Pharmacopeial Convention
12601 Twinbrook Parkway
Rockville, Maryland 20852

**Donnette D. Staas, PhD
Expertise: Industry Representative
Term: 2/8/2024 to 10/31/2027
Vice President, Regulatory Strategy
Jazz Pharmaceuticals
2005 Market Street, Suite 2100
Philadelphia, Pennsylvania 19103

Allen J. Vaida, BSc, PharmD, FASHP
Expertise: Public Health Advocacy, Medication Safety
Term: 6/3/2021 – 9/30/2025
Former Executive Vice President
Institute for Safe Medication Practices
Hatfield, Pennsylvania 19440-2040

* Consumer Representative (vacant)
** Industry Representative (non-voting)

 

Back to Top